References - iarc

244. Berkowitz RS, Cramer DW, Bernstein
MR, Cassells S, Driscoll SG, Goldstein DP
(1985). Risk factors for complete molar
pregnancy from a case-control study. Am
J Obstet Gynecol 152: 1016-1020.
245. Berkowitz RS, Ehrmann RL, Knapp RC
(1978). Endometrial stromal sarcoma arising
from vaginal endometriosis. O b s t e t
Gynecol 51: 34s-37s.
246. Berliant II (1970). [Neurofibroma of the
broad ligament of the uterus]. A k u s h
Ginekol (Mosk) 46: 70-71.
247. Berman ML, Soper JT, Creasman WT,
Olt GT, Disaia PJ (1989). Conservative surgical
management of superficially invasive
stage I vulvar carcinoma. Gynecol Oncol
35: 352-357.
248. Bermudez A, Vighi S, Garcia A, Sardi J
(2001). Neuroendocrine cervical carcinoma:
a diagnostic and therapeutic challenge.
Gynecol Oncol 82: 32-39.
249. Berns EM, Foekens JA, Vossen R,
Look MP, Devilee P, Henzen-Logmans SC,
van Staveren IL, van Putten WL, Inganas
M, Meijer-van Gelder ME, Cornelisse C,
Claassen CJ, Portengen H, Bakker B, Klijn
JG (2000). Complete sequencing of TP53
predicts poor response to systemic therapy
of advanced breast cancer. Cancer Res
60: 2155-2162.
250. Berns EM, Klijn JG, van Putten WL,
van Staveren IL, Portengen H, Foekens JA
(1992). c-myc amplification is a better
prognostic factor than HER2/neu amplification
in primary breast cancer. Cancer
Res 52: 1107-1113.
251. Berns EM, van Staveren IL, Look MP,
Smid M, Klijn JG, Foekens JA (1998).
Mutations in residues of TP53 that directly
contact DNA predict poor outcome in
human primary breast cancer. Br J Cancer
77: 1130-1136.
252. Bernstein JL, Thompson WD, Risch N,
Holford TR (1992). Risk factors predicting
the incidence of second primary breast
cancer among women diagnosed with a
first primary breast cancer. Am J
Epidemiol 136: 925-936.
253. Bernstein JL, Thompson WD, Risch N,
Holford TR (1992). The genetic epidemiolo -
gy of second primary breast cancer. Am J
Epidemiol 136: 937-948.
254. Bernstein L, Deapen D, Ross RK (1993).
The descriptive epidemiology of malignant
cystosarcoma phyllodes tumors of the
breast. Cancer 71: 3020-3024.
255. Bernstein L, Ross RK (1993).
Endogenous hormones and breast cancer
risk. Epidemiol Rev 15: 48-65.
256. Berrino F, Capocaccia R, Esteve J,
Gatta G, Hakulinen T, Micheli A, Sant M,
Verdecchia A (1999). Survival of Cancer
patients in Europe: The EUROCARE-2
Study. IARC Scientific Publication No 151.
International Agency for Research on
Cancer: Lyon.
257. Bertucci F, Nasser V, Granjeaud S,
Eisinger F, Adelaide J, Tagett R, Loriod B,
Giaconia A, Benziane A, Devilard E,
Jacquemier J, Viens P, Nguyen C,
Birnbaum D, Houlgatte R (2002). Gene
expression profiles of poor-prognosis primary
breast cancer correlate with survival.
Hum Mol Genet 11: 863-872.
258. Bertwistle D, Swift S, Marston NJ,
Jackson LE, Crossland S, Crompton MR,
Marshall CJ, Ashworth A (1997). Nuclear
location and cell cycle regulation of the
BRCA2 protein. Cancer Res 57: 5485-5488.
259. Berx G, Becker KF, Hofler H, van Roy F
(1998). Mutations of the human E-cadherin
(CDH1) gene. Hum Mutat 12: 226-237.
376 References
260. Berx G, Cleton-Jansen AM, Nollet F,
de Leeuw WJ, van de Vijvert M, Cornelisse
C, van Roy F (1995). E-cadherin is a
tumour/invasion suppressor gene mutated
in human lobular breast cancers. EMBO J
14: 6107-6115.
261. Berx G, Cleton-Jansen AM, Strumane
K, de Leeuw WJ, Nollet F, van Roy F,
Cornelisse C (1996). E-cadherin is inactivated
in a majority of invasive human lobular
breast cancers by truncation mutations
throughout its extracellular domain.
Oncogene 13: 1919-1925.
262. Bethwaite PB, Holloway LJ, Yeong
ML, Thornton A (1993). Effect of tumour
associated tissue eosinophilia on survival
of women with stage IB carcinoma of the
uterine cervix. J Clin Pathol 46: 1016-1020.
263. Bethwaite PB, Koreth J, Herrington
CS, McGee JO (1995). Loss of heterozygosity
occurs at the D11S29 locus on chromosome
11q23 in invasive cervical carcinoma.
Br J Cancer 71: 814-818.
264. Biankin SA, O’Toole VE, Fung C,
Russell P (2000). Bizarre leimyoma of the
vagina: Report of a case. Int J Gynecol
Pathol 19: 186-187.
265. Bieche I, Lidereau R (1995). Genetic
alterations in breast cancer. G e n e s
Chromosomes Cancer 14: 227-251.
266. Bieche I, Lidereau R (1999). Increased
level of exon 12 alternatively spliced
BRCA2 transcripts in tumor breast tissue
compared with normal tissue. Cancer Res
59: 2546-2550.
267. Bieche I, Nogues C, Lidereau R (1999).
Overexpression of BRCA2 gene in sporadic
breast tumours. Oncogene 18: 5232-5238.
268. Bienenstock J, Befus AD (1980).
Mucosal immunology. Immunology 41: 249-
270.
269. Biernat W, Jablkowski W (2000).
Syringomatous adenoma of the nipple. Pol
J Pathol 51: 201-202.
270. Bijker N, Peterse JL, Duchateau L,
Robanus-Maandag EC, Bosch CA, Duval C,
Pilotti S, Van de Vijver MJ (2001).
Histological type and marker expression of
the primary tumour compared with its local
recurrence after breast-conserving therapy
for ductal carcinoma in situ. Br J
Cancer 84: 539-544.
271. Bijker N, Rutgers EJ, Peterse JL,
Fentiman IS, Julien JP, Duchateau L, van
Dongen JA (2001). Variations in diagnostic
and therapeutic procedures in a multicentre,
randomized clinical trial (EORTC 10853)
investigating breast-conserving treatment
for DCIS. Eur J Surg Oncol 27: 135-140.
272. Bingham C, Roberts D, Hamilton TC
(2001). The role of molecular biology in
understanding ovarian cancer initiation
and progression. Int J Gynecol Cancer 11
Suppl 1: 7-11.
273. Birch JM, Hartley AL, Blair V, Kelsey
AM, Harris M, Teare MD, Jones PH (1990).
Cancer in the families of children with soft
tissue sarcoma. Cancer 66: 2239-2248.
274. Birkeland SA, Storm HH, Lamm LU,
Barlow L, Blohme I, Forsberg B, Eklund B,
Fjeldborg O, Friedberg M, Frodin L, Glattre
E, Halvorsen S, Holm NV, Jakobsen A,
Jorgensen HE, Ladefoged J, Lindholm T,
Lundgren G, Pukkala E. (1995). Cancer risk
after renal transplantation in the Nordic
countries, 1964-1986. Int J Cancer 60: 183-
189.
275. Bisceglia M, Attino V, D'Addetta C,
Murgo R, Fletcher CD (1996). [Early stage
Stewart-Treves syndrome: report of 2
cases and review of the literature].
Pathologica 88: 483-490.
276. Bisceglia M, Fusilli S, Zaffarano L,
Fiorentino F, Tardio B (1995). [Inflammatory
pseudotumor of the breast. Report of a
case and review of the literature].
Pathologica 87: 59-64.
277. Biscotti CV, Hart WR (1989). Juvenile
granulosa cell tumors of the ovary. Arch
Pathol Lab Med 113: 40-46.
278. Biscotti CV, Hart WR (1992). Peritoneal
serous micropapillomatosis of low malignant
potential (serous borderline tumors of
the peritoneum). A clinicopathologic study
of 17 cases. Am J Surg Pathol 16: 467-475.
279. Biscotti CV, Hart WR (1998). Apoptotic
bodies: a consistent morphologic feature
of endocervical adenocarcinoma in situ.
Am J Surg Pathol 22: 434-439.
2 8 0 . Bishara M, Scapa E (1997). [Stromal
uterine sarcoma arising from intestinal
endometriosis after abdominal hysterectomy
and salpingo-oophorectomy]. H a r e f u a h
133: 353-355.
281. Bishop DT, Hopper J (1997). AT-tributable
risks? Nat Genet 15: 226.
2 8 2 . Bitterman P, Chun B, Kurman RJ
(1990). The significance of epithelial differentiation
in mixed mesodermal tumors of
the uterus. A clinicopathologic and
immunohistochemical study. Am J Surg
Pathol 14: 317-328.
283. Bjorkholm E, Silfversward C (1980).
Theca-cell tumors. Clinical features and
prognosis. Acta Radiol Oncol 19: 241-244.
284. Bjorkholm E, Silfversward C (1981).
Prognostic factors in granulosa-cell
tumors. Gynecol Oncol 11: 261-274.
285. Black CL, Morris DM, Goldman LI,
McDonald JC (1983). The significance of
lymph node involvement in patients with
medullary carcinoma of the breast. Surg
Gynecol Obstet 157: 497-499.
286. Black MM, Barclay TH, Hankey BF
(1975). Prognosis in breast cancer utilizing
histologic characteristics of the primary
tumor. Cancer 36: 2048-2055.
287. Blaker H, Graf M, Rieker RJ, Otto HF
(1999). Comparison of losses of heterozygosity
and replication errors in primary
colorectal carcinomas and corresponding
liver metastases. J Pathol 188: 258-262.
288. Blamey RW (1998). Clinical aspects of
malignant breast lesions In: Systemic
Pathology, CW Elston, IO Ellis (Eds.). 3rd
ed. Churchill Livingstone: Edinburgh, pp.
501-513.
289. Bloch T, Roth LM, Stehman FB, Hull
MT, Schwenk GR Jr. (1988). Osteosarcoma
of the uterine cervix associated with
hyperplastic and atypical mesonephric
rests. Cancer 62: 1594-1600.
290. Block E (1947). Squamous cell carcinoma
of the fallopian tube. Acta Radiol 28:
49-68.
291. Blom R, Guerrieri C, Stal O, Malmstrom
H, Simonsen E (1998). Leiomyosarcoma of
the uterus: A clinicopathologic, DNA flow
cytometric, p53, and mdm-2 analysis of 49
cases. Gynecol Oncol 68: 54-61.
292. Blom R, Malmstrom H, Guerrieri C
(1999). Endometrial stromal sarcoma of the
uterus: a clinicopathologic, DNA flow cytometric,
p53, and mdm-2 analysis of 17
cases. Int J Gynecol Cancer 9: 98-104.
293. Bloom HJ, Richardson WW (1957).
Histological grading and prognosis in
breast cancer. Br J Cancer 11: 359-377.
294. Bloom HJ, Richardson WW, Field JR
(1970). Host resistance and survival in car -
cinoma of breast: a study of 104 cases of
medullary carcinoma in a series of 1,411
cases of breast cancer followed for 20
years. Br Med J 3: 181-188.
295. Boardman CH, Webb MJ, Jefferies JA
(2000). Low-grade endometrial stromal sarcoma
of the ectocervix after therapy for
breast cancer. Gynecol Oncol 79: 120-123.
296. Bobrow LG, Richards MA, Happerfield
LC, Diss TC, Isaacson PG, Lammie GA,
Millis RR (1993). Breast lymphomas: a clin -
icopathologic review. Hum Pathol 24: 274-
278.
297. Bochar DA, Wang L, Beniya H, Kinev
A, Xue Y, Lane WS, Wang W, Kashanchi F,
Shiekhattar R (2000). BRCA1 is associated
with a human SWI/SNF-related complex:
linking chromatin remodeling to breast
cancer. Cell 102: 257-265.
298. Bodian CA, Perzin KH, Lattes R (1996).
Lobular neoplasia. Long term risk of breast
cancer and relation to other factors.
Cancer 78: 1024-1034.
2 9 9 . Bodian CA, Perzin KH, Lattes R,
Hoffmann P, Abernathy TG (1993).
Prognostic significance of benign proliferative
breast disease. Cancer 71: 3896-3907.
300. Bodner K, Bodner-Adler B, Obermair
A, Windbichler G, Petru E, Mayerhofer S,
Czerwenka K, Leodolter S, Kainz C,
Mayerhofer K (2001). Prognostic parameters
in endometrial stromal sarcoma: a
clinicopathologic study in 31 patients.
Gynecol Oncol 81: 160-165.
301. Boecker W, Buerger H, Schmitz K, Ellis
IA, van Diest PJ, Sinn H-P, Geradts J,
Diallo R, Poremba C, Herbst H (2001).
Ductal epithelial proliferations of the
breast: a biological continuum? Comparative
genomic hybridization an highmolecular-weight
cytokeratin expression
patterns. J Pathol 195: 415-421.
302. Bohm J, Roder-Weber M, Hofler H,
Kolben M (1991). Bilateral stromal Leydig
cell tumour of the ovary. Case report and
literature review. Pathol Res Pract 187:
348-352.
303. Boice JD Jr., Engholm G, Kleinerman
RA, Blettner M, Stovall M, Lisco H,
Moloney WC, Austin DF, Bosch A, Cookfair
DL, Krementz ET, Latourettte HB, Merrill
JA, Peters LJ, Schultz MD, Strom HH,
Bjorkholm E, Pettersson F, Bell CMJ,
Coleman MP, Fraser P, Neal FE, Prior P,
Choi NW, Hislop TG, Koch M, Kreiger N,
Robb D, Robson D, Thomson DH,
Lochmuller H, Vonfournier D, Frischkorn R,
Kjorstad KE, Rimpela A, Pejovic MH, Kirn
VP, Stankusova H, Berrino F, Sigurdsson K,
Hutchinson GB, Macmahon B (1988).
Radiation dose and second cancer risk in
patients treated for cancer of the cervix.
Radiat Res 116: 3-55.
304. Boice JD Jr., Preston D, Davis FG,
Monson RR (1991). Frequent chest X-ray
fluoroscopy and breast cancer incidence
among tuberculosis patients in
Massachusetts. Radiat Res 125: 214-222.
305. Boks D.E., Trujillo A.P., Voogd AC,
Morreau H, Kenter GG, Vasen HF (2002).
Survival analysis of endometrial carcinoma
asociated with hereditary nonpolyposis
colorectal cancer. Int J Cancer 102: 198-
200.
306. Boland CR, Thibodeau SN, Hamilton
SR, Sidransky D, Eshleman JR, Burt RW,
Meltzer SJ, Rodriguez-Bigas MA, Fodde R,
Ranzani GN, Srivastava S (1998). A
National Cancer Institute Workshop on
Microsatellite Instability for cancer detection
and familial predisposition: development
of international criteria for the deter -
mination of microsatellite instability in
colorectal cancer. Cancer Res 58: 5248-
5257.